CCL Industries (CCL-B) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
Sales for 2025 reached $7.66 billion, up 5.8% year-over-year, with Q4 sales rising 3.5% to nearly $1.88 billion; organic growth was 0.6% in Q4, with positive currency and acquisition impacts.
Operating income for 2025 increased 8.7% to $1,241.5 million, with Q4 operating income at $280.7 million, up 2% excluding currency effects.
Adjusted basic EPS for 2025 was $4.64, up 7.4%, and $1.03 in Q4, up 1% year-over-year.
Net earnings declined in 2025 due to higher tax expense and absence of a prior-year non-cash gain.
Returned $523.7 million to shareholders through dividends and share repurchases, a 29% increase year-over-year.
Financial highlights
Adjusted EBITDA for 2025 was $1,622.5 million, up from $1,497.1 million in 2024; Q4 EBITDA was $383.6 million, up 3%.
Free cash flow from operations reached a record $891.3 million, up 47% year-over-year.
Net debt at year-end 2025 was $1.26 billion, with a leverage ratio of 0.78x Adjusted EBITDA.
Effective tax rate increased to 28.5% in Q4 and 25.9% for the year, mainly due to higher withholding taxes.
Nearly $1 billion in cash on hand and $1 billion undrawn credit capacity at year-end.
Outlook and guidance
Expecting low to mid-single-digit organic growth in 2026, with Q1 likely more challenging due to weather-related freight disruptions.
RFID business at Checkpoint anticipated to return to double-digit growth in 2026, driven by normalization in apparel inventory and new applications.
Tax rate for 2026 projected around 25%, with less volatility from withholding taxes.
CapEx for 2026 estimated at $470 million, focused on greenfield projects and capacity expansion.
No margin expansion planned for 2026 in the CCL segment; margins expected to remain within historical ranges.
Latest events from CCL Industries
- Q2 2024 saw record sales, profit, and EPS, driven by organic growth and a major acquisition gain.CCL-B
Q2 20241 Feb 2026 - Q3 delivered strong sales and earnings growth, led by Checkpoint and Innovia, with robust liquidity.CCL-B
Q3 202414 Jan 2026 - Q1 2025 saw record sales, earnings, and cash flow, with robust shareholder returns.CCL-B
Q1 20258 Jan 2026 - Record 2024 sales and earnings, strong cash flow, and positive but cautious 2025 outlook.CCL-B
Q4 20248 Jan 2026 - Q2 2025 saw record adjusted EPS, strong cash flow, and robust shareholder returns despite tariff headwinds.CCL-B
Q2 202523 Nov 2025 - Q3 sales and earnings rose, led by CCL and Checkpoint, with strong cash flow and $467.9M returned.CCL-B
Q3 202512 Nov 2025